Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morris D Groves

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Current Oncology Reports|December 21, 2002
The pathogenesis of neoplastic meningitisMorris D Groves
Neurosurgery Clinics of North America|November 27, 2010
Leptomeningeal diseaseMorris D Groves
Archives of Neurology|March 10, 2010
New strategies in the management of leptomeningeal metastasesMorris D Groves
Neurology|May 24, 2006
CSF levels of angiogenesis-related proteins in patients with leptomeningeal metastasesMorris D Groves
Future Oncology (London, England)|February 12, 2010
Known and emerging biomarkers of leptomeningeal metastasis and its response to treatmentTobias Walbert, Morris D Groves
Current Treatment Options in Neurology|April 19, 2011
High-grade gliomasBrett J Theeler, Morris D Groves
Current Oncology Reports|April 29, 2010
Biology and therapy of neoplastic meningitisAaron G Mammoser, Morris D Groves
Continuum (Minneapolis, Minn.)|July 20, 2012
Helping patients make the best decision regarding duration of temozolomide chemotherapy treatmentMorris D Groves, Ava B Plummer
Journal of Neuro-Oncology|April 10, 2008
Low grade astrocytoma presenting with visual lossMorris D Groves, Ruth L Katz
Neuro-Oncology|August 19, 2008
Prognostic factors and outcomes in patients with leptomeningeal melanomatosisLaura Harstad, Kenneth R Hess, Morris D Groves
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Current Oncology Reports|December 21, 2002
The pathogenesis of neoplastic meningitisMorris D Groves
Neurosurgery Clinics of North America|November 27, 2010
Leptomeningeal diseaseMorris D Groves
Archives of Neurology|March 10, 2010
New strategies in the management of leptomeningeal metastasesMorris D Groves
Neurology|May 24, 2006
CSF levels of angiogenesis-related proteins in patients with leptomeningeal metastasesMorris D Groves
Future Oncology (London, England)|February 12, 2010
Known and emerging biomarkers of leptomeningeal metastasis and its response to treatmentTobias Walbert, Morris D Groves
Current Treatment Options in Neurology|April 19, 2011
High-grade gliomasBrett J Theeler, Morris D Groves
Current Oncology Reports|April 29, 2010
Biology and therapy of neoplastic meningitisAaron G Mammoser, Morris D Groves
Continuum (Minneapolis, Minn.)|July 20, 2012
Helping patients make the best decision regarding duration of temozolomide chemotherapy treatmentMorris D Groves, Ava B Plummer
Journal of Neuro-Oncology|April 10, 2008
Low grade astrocytoma presenting with visual lossMorris D Groves, Ruth L Katz
Neuro-Oncology|August 19, 2008
Prognostic factors and outcomes in patients with leptomeningeal melanomatosisLaura Harstad, Kenneth R Hess, Morris D Groves
Pageof 6